Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Arcturus Therapeutics Holdings Inc have a median target of 70.00, with a high estimate of 140.00 and a low estimate of 25.00. The median estimate represents a 310.08% increase from the last price of 17.07.
High | 720.2% | 140.00 |
Med | 310.1% | 70.00 |
Low | 46.5% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | -17.40% |
Average growth rate | -91.57% |
More ▼
Revenue history & estimates in USD
Average growth rate | +0.47% |
Average growth rate | +379.91% |
More ▼